Phase 1b-2 Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant PC....anyone doing this one?

[MontyB]

Is anyone taking part in or have experience with this clinical trial?

Scarlino asked about this 4 months ago and although he received several replies, unless I'm mistaken there were no replies from anyone with experience with or in this trial. The goal of this trial is to learn if niraparib (also known as ZEJULA®) when used in combination with JNJ-63723283 can help to control metastatic (has spread) castration-resistant prostate cancer (mCRPC).

I'm asking again today...hoping that possibly someone here on HealthUnlocked has started this trial since scarlino asked 4 months ago.

[Tall_Allen]

Because there are only 60 participants in the worldwide study, I think the odds of finding one on this site to talk to are small. You may have more luck in asking your doctor (or possibly the lead investigator at Janssen) if there is anyone you can speak to about it who has been enrolled in it. They can't give anyone's contact info without his permission, of course, but sometimes participants volunteer to talk to others - I did when I was in a clinical trial.

[MontyB in reply to Tall_Allen]

Thanks Tall_Allen. Good advice. You are right...no question...the odds are very small here, but I thought it was worth a shot. If there are no participants here who reply, I'll do as you suggest and start with asking the study medical team if there are any participants who may be willing to discuss it with me.

[MontyB]

Thanks Nalakrats. Yes, you are right...it is an investigational immune checkpoint inhibitor...or to me...an immunotherapy drug. I was hoping there might be a patient here taking part in it who I could talk (PM) with about it. Would love to get a patient participant's perspective on it.

[MontyB]

Thank you Nalakrats!